244 related articles for article (PubMed ID: 21256922)
41. The interplay between BDNF and oxidative stress in chronic schizophrenia.
Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Okusaga OO; Zunta-Soares GB; Soares JC
Psychoneuroendocrinology; 2015 Jan; 51():201-8. PubMed ID: 25462893
[TBL] [Abstract][Full Text] [Related]
42. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine.
Gama CS; Salvador M; Andreazza AC; Kapczinski F; Silva Belmonte-de-Abreu P
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):512-5. PubMed ID: 16426720
[TBL] [Abstract][Full Text] [Related]
43. Changes in serum levels of brain derived neurotrophic factor and nerve growth factor-beta in schizophrenic patients before and after treatment.
Ajami A; Hosseini SH; Taghipour M; Khalilian A
Scand J Immunol; 2014 Jul; 80(1):36-42. PubMed ID: 24498860
[TBL] [Abstract][Full Text] [Related]
44. Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease.
Leyhe T; Eschweiler GW; Stransky E; Gasser T; Annas P; Basun H; Laske C
J Alzheimers Dis; 2009; 16(3):649-56. PubMed ID: 19276559
[TBL] [Abstract][Full Text] [Related]
45. Serum brain-derived neurotrophic factor and platelet activation evaluated by soluble P-selectin and soluble CD-40-ligand in patients with acute myocardial infarction.
Lorgis L; Amoureux S; de Maistre E; Sicard P; Bejot Y; Zeller M; Vergely C; Sequeira-Le Grand A; Lagrost AC; Berchoud J; Cottin Y; Rochette L
Fundam Clin Pharmacol; 2010 Aug; 24(4):525-30. PubMed ID: 19909348
[TBL] [Abstract][Full Text] [Related]
46. Brain-derived neurotropic factor/TrkB signaling in the pathogenesis and novel pharmacotherapy of schizophrenia.
Pillai A
Neurosignals; 2008; 16(2-3):183-93. PubMed ID: 18253057
[TBL] [Abstract][Full Text] [Related]
47. [Could we use a serum level of glycine as a prognostic factor of its efficacy in schizophrenic patients?].
Strzelecki D; Rabe-Jabłońska J
Psychiatr Pol; 2010; 44(3):395-404. PubMed ID: 20672518
[TBL] [Abstract][Full Text] [Related]
48. Serum brain-derived neurotrophic factors in Taiwanese patients with drug-naïve first-episode schizophrenia: Effects of antipsychotics.
Chiou YJ; Huang TL
World J Biol Psychiatry; 2017 Aug; 18(5):382-391. PubMed ID: 27643618
[TBL] [Abstract][Full Text] [Related]
49. Serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia.
Xiang YQ; Zhang ZJ; Weng YZ; Zhai YM; Li WB; Cai ZJ; Tan QR; Wang CY
Schizophr Res; 2006 Apr; 83(2-3):201-10. PubMed ID: 16524698
[TBL] [Abstract][Full Text] [Related]
50. Association between serum levels of glutamate and neurotrophic factors and response to clozapine treatment.
Krivoy A; Hochman E; Sendt KV; Hollander S; Vilner Y; Selakovic M; Weizman A; Taler M
Schizophr Res; 2018 Feb; 192():226-231. PubMed ID: 28599751
[TBL] [Abstract][Full Text] [Related]
51. Serum concentrations of brain-derived neurotrophic factor in patients with gender identity disorder.
Fontanari AM; Andreazza T; Costa ÂB; Salvador J; Koff WJ; Aguiar B; Ferrari P; Massuda R; Pedrini M; Silveira E; Belmonte-de-Abreu PS; Gama CS; Kauer-Sant'Anna M; Kapczinski F; Lobato MI
J Psychiatr Res; 2013 Oct; 47(10):1546-8. PubMed ID: 23702250
[TBL] [Abstract][Full Text] [Related]
52. Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia.
Niitsu T; Shirayama Y; Matsuzawa D; Hasegawa T; Kanahara N; Hashimoto T; Shiraishi T; Shiina A; Fukami G; Fujisaki M; Watanabe H; Nakazato M; Asano M; Kimura S; Hashimoto K; Iyo M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1836-40. PubMed ID: 21930178
[TBL] [Abstract][Full Text] [Related]
53. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
Hori H; Yoshimura R; Katsuki A; Atake K; Igata R; Konishi Y; Nakamura J
World J Biol Psychiatry; 2017 Aug; 18(5):401-408. PubMed ID: 27409727
[TBL] [Abstract][Full Text] [Related]
54. Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls.
Shimizu E; Hashimoto K; Watanabe H; Komatsu N; Okamura N; Koike K; Shinoda N; Nakazato M; Kumakiri C; Okada S; Iyo M
Neurosci Lett; 2003 Nov; 351(2):111-4. PubMed ID: 14583394
[TBL] [Abstract][Full Text] [Related]
55. Decreased serum brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia.
Yang YQ; Sun S; Yu YQ; Li WJ; Zhang X; Xiu MH; Chen DC; De Yang F; Liu H; Li C; Kosten TR; Zhang XY
Neurosci Lett; 2011 Sep; 502(1):37-40. PubMed ID: 21798311
[TBL] [Abstract][Full Text] [Related]
56. Sex differences in the association between serum BDNF and cognitive impairment in schizophrenia patients using various antipsychotics.
Dong R; Zhao NO; Wu HE; Yu L; Zhang XY
J Psychiatr Res; 2021 Jun; 138():492-499. PubMed ID: 33971483
[TBL] [Abstract][Full Text] [Related]
57. Safety of long-term clozapine administration. Frequency of cardiomyopathy and hyponatraemia: two cross-sectional, naturalistic studies.
Serrano A; Rangel N; Carrizo E; Uzcátegui E; Sandia I; Zabala A; Fernández E; Tálamo E; Servigna M; Prieto D; Connell L; Baptista T
Aust N Z J Psychiatry; 2014 Feb; 48(2):183-92. PubMed ID: 23985160
[TBL] [Abstract][Full Text] [Related]
58. Blood Pressure and Heart Rate Changes During Clozapine Treatment.
Norman SM; Sullivan KM; Liu F; DiPaula BA; Jose PA; Kitchen CA; Feldman SM; Kelly DL
Psychiatr Q; 2017 Sep; 88(3):545-552. PubMed ID: 27678498
[TBL] [Abstract][Full Text] [Related]
59. The clozapine to norclozapine ratio: a narrative review of the clinical utility to minimize metabolic risk and enhance clozapine efficacy.
Costa-Dookhan KA; Agarwal SM; Chintoh A; Tran VN; Stogios N; Ebdrup BH; Sockalingam S; Rajji TK; Remington GJ; Siskind D; Hahn MK
Expert Opin Drug Saf; 2020 Jan; 19(1):43-57. PubMed ID: 31770500
[No Abstract] [Full Text] [Related]
60. Interaction of BDNF with cytokines in chronic schizophrenia.
Zhang XY; Tan YL; Chen DC; Tan SP; Yang FD; Wu HE; Zunta-Soares GB; Huang XF; Kosten TR; Soares JC
Brain Behav Immun; 2016 Jan; 51():169-175. PubMed ID: 26407757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
